TY  - JOUR
AU  - Martínez-Iglesias, Olaia
AU  - Olmeda, David
AU  - Alonso-Merino, Elvira
AU  - Gómez-Rey, Sara
AU  - González-López, Ana M
AU  - Luengo, Enrique
AU  - Soengas, MS
AU  - Palacios, José
AU  - Regadera, Javier
AU  - Aranda, Ana
PY  - 2016
DO  - 10.18632/oncotarget.12978
SN  - 1949-2553
UR  - http://hdl.handle.net/20.500.12105/8875
AB  - Vascular Endotelial Growth Factors C and D (VEGF-C and VEGF-D) are crucial regulators of lymphangiogenesis, a main event in the metastatic spread of breast cancer tumors. Although inhibition of lymphangiogenic gene expression might be a useful...
LA  - eng
PB  - Impact Journals
KW  - VEGFs
KW  - Breast cancer
KW  - Lymphangiogenesis
KW  - Nuclear receptor corepressor 1
KW  - Thyroid hormone receptor beta 1
KW  - Animals
KW  - Breast Neoplasms
KW  - Cell Line, Tumor
KW  - Female
KW  - Humans
KW  - Lymphatic Metastasis
KW  - MCF-7 Cells
KW  - Mice
KW  - Neoplasm Invasiveness
KW  - Neoplasm Transplantation
KW  - Nuclear Receptor Co-Repressor 1
KW  - Prognosis
KW  - Thyroid Hormone Receptors beta
KW  - Transcription, Genetic
KW  - Vascular Endothelial Growth Factor C
KW  - Vascular Endothelial Growth Factor D
KW  - Vesicular Transport Proteins
TI  - The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis
TY  - journal article
ER  -